Bluebird Bio reported $254.92M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Amgen AMGN:US $ 18520M 865M
Applied Genetic Technologies AGTC:US $ 70.53M 4.84M
Arrowhead Research ARWR:US $ 417.63M 79.35M
Avrobio Inc AVRO:US 170.92M 28.22M
Biogen BIIB:US $ 7915.9M 59.4M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Gilead Sciences GILD:US $ 12629M 2143M
Immunogen IMGN:US $ 456.72M 43.28M
Intercept Pharmaceuticals ICPT:US $ 477.35M 24.94M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Moderna Inc MRNA:US 16.35B 279M
Nektar Therapeutics NKTR:US $ 733.46M 62.13M
Novartis NOVN:VX 37.24B 8.48B
Pfizer PFE:US $ 54420M 5273M
Ptc Therapeutics PTCT:US $ 774.01M 180.36M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Seattle Genetics SGEN:US $ 2771.26M 97.94M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
YTE INCY:US $ 3288.09M 169.42M